Price Performance
- Day's Low
- ₹98.4
- Day's High
- ₹100.65
₹ 100.3
- 52-w low
- ₹77.5
- 52-w high
- ₹132.45
100.3
- Day's open
₹98.4 - Previous close
₹98.3 - VWAP
₹100.19 - Lower price band
₹80.25 - Upper price band
₹120.35
Today's Market Action
The last traded share price of Bal Pharma Ltd was 100.30 up by 2.24% on the NSE. Its last traded stock price on BSE was 100.18 up by 1.79%. The total volume of shares on NSE and BSE combined was 8,988 shares. Its total combined turnover was Rs 0.09 crores.
Medium and Long Term Market Action
Bal Pharma Ltd hit a 52-week high of 132.45 on 02-02-2024 and a 52-week low of 77.5 on 26-04-2023.
The stock price of Bal Pharma Ltd is up by 10% over the last one month. It is up by 27.37% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 159
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Bal Pharma Ltd?
What is the Market Cap of Bal Pharma Ltd?
What is PE Ratio of Bal Pharma Ltd?
What is PB Ratio of Bal Pharma Ltd?
What is the CAGR of Bal Pharma Ltd?
How to Buy Bal Pharma Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
- No Data Available
Cons
Momentum Strength
Low Sustainable RoE
Low Return on Capital Employed
Poor Cash Flow Conversion
Low Interest Coverage
Highly Cyclical Industry
Low Pricing Power & High Competition
High Debt
Poor Capital Allocation
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(27/04/2024)
(27/04/2024)
101
0.00%
0.00% People are bullish about Bal Pharma Ltd
100.00%
100.00 % People are bearish about Bal Pharma Ltd